INCIDENCE OF Delirium After Cardiac SURGERY Surgery

July 22, 2021 updated by: Smriti Mahaju Bajracharya,MD, Shahid Gangalal National Heart Centre

Incidence And Predictors of Delirium After Cardiac Surgery; A Prospective Observational Cohort Study From a Single Tertiary Referral Centre

Delirium is a common problem that occurs after cardiac surgery. The incidence of delirium after cardiac surgery is estimated to be 26-52%, with a significant percentage being hypoactive delirium1-4.Postoperative delirium has been associated with higher hospital costs, longer lengths of hospital stay, increased likelihood of institutionalization, increased risk for dementia, and increased morbidity and mortality.5-7 .

The overall purpose of this study was to determine the incidence and perioperative factors that predispose to cause delirium in postoperative cardiac surgery patients in our ICU

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

234

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kathmandu, Nepal, 11360
        • Shahid Gangalal National Heart Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients 18 years old and older of both sexes who are undergoing cardiac surgery in a single centre

Description

Inclusion Criteria:

  • Patients 18 years old and older of both sexes
  • Patients who signed an informed consent
  • Patients scheduled for cardiac surgery with extracorporeal circulation (coronary-artery bypass grafting (CABG), cardiac valve replacement (CVR), combined CABG + CVR, excision of cardiac myxoma)

Exclusion Criteria:

  • Patients who refused to participate before or after operation;
  • Patients in poor general condition;
  • Patients with preoperative dementia, delirium or illiterate, psychiatric or mental disorder (epilepsy, schizophrenia, depression);
  • Patients who died intraoperatively or within the first 6 hours after the procedure.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Without delirium
With delirium

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
incidence and perioperative factors that predispose to cause delirium in postoperative cardiac surgery patients in our ICU
Time Frame: 6 months
Incidence and perioperative risk factors that may predispose to delirium after cardiac surgery in our settings
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ICU stay and mechanical ventilation time
Time Frame: 6 months
whetherICU stay in days and mechanical ventilation time in number of hours is affected by delirium
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2018

Primary Completion (ACTUAL)

December 30, 2018

Study Completion (ACTUAL)

December 30, 2018

Study Registration Dates

First Submitted

July 12, 2021

First Submitted That Met QC Criteria

July 22, 2021

First Posted (ACTUAL)

August 2, 2021

Study Record Updates

Last Update Posted (ACTUAL)

August 2, 2021

Last Update Submitted That Met QC Criteria

July 22, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delirium

3
Subscribe